Bin Shao

Sichuan University

H指数:31

被引数:3,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term survival outcomes and subtype variations between primary breast cancer and liver metastases in 542 patients with advanced breast cancer: insights from a real-world analysis

542例晚期乳腺癌患者中，原发乳腺癌与肝脏转移瘤的长期生存结局及亚型变异比较：来自真实世界分析的研究启示

Discover Oncology

IF2.9

2025-08-070

OAAI

Enhanced Mass Transport in the Electrical Double Layer for Hydrogen Electrocatalysis toward Long-Life Ni–H2 Batteries

电化学双层中增强的质量传输，用于面向长寿命Ni–H2电池的氢电催化

ACS Sustainable Chemistry & Engineering

IF7.3

2025-08-040

PRE

Myeloid-derived suppressor cell-targeted virus-like particles synergistically activate innate immune response for cancer immunotherapy

髓系来源抑制细胞靶向病毒样颗粒协同激活先天免疫反应，用于癌症免疫治疗

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-05-010

PRE

A20 as a Potential Therapeutic Target for COVID-19

A20作为新型冠状病毒肺炎的潜在治疗靶点

IMMUNITY INFLAMMATION AND DISEASE

IF2.7

2025-01-240

Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study

BMC CANCER

IF3.4

2025-01-031

OAAI

Ultra-sensitive ctDNA NGS assay enhances genomic profiling for advanced HR-positive, HER2-negative breast cancer on endocrine therapy

超敏感ctDNA NGS检测方法增强了内分泌治疗中晚期HR阳性、HER2阴性乳腺癌的基因组分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Inhibition of NLRP3 inflammasome activation by A20 through modulation of NEK7

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-06-121

OAAI

Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7

ADVANCED SCIENCE

IF14.1

2024-05-026

Functionalized Virus Nanoparticles Alleviates Osteoporosis via Targeting the Function of RANK-Specific Motifs

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-06-290

PRE

Epigenetic regulation and therapeutic targets in the tumor microenvironment

MOLECULAR BIOMEDICINE

IF10.1

2023-06-0520

OAAI

Engineered Plant Virus Complexes with a RANK Motif Modulator and Bone Targeting for Osteoporosis Treatment

具有RANK基序调节剂和骨靶向的工程化植物病毒复合物用于骨质疏松症治疗

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-02-231

PRE

AFF4 regulates cellular adipogenic differentiation via targeting autophagy

AFF4通过靶向自噬调节细胞成脂分化

PLOS GENETICS

IF3.7

2022-09-236

OAAI

Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-056

OAAI

Targeting the Macrophage-Ferroptosis Crosstalk: A Novel Insight into Tumor Immunotherapy

靶向巨噬细胞-铁死亡串扰: 肿瘤免疫治疗的新见解

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2022-06-2723

HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-06-0411

Phosphatidylserine released from apoptotic cells in tumor induces M2-like macrophage polarization through the PSR-STAT3-JMJD3 axis

肿瘤凋亡细胞释放的磷脂酰丝氨酸通过PSR-STAT3-JMJD3轴诱导巨噬细胞M2-like极化

CANCER COMMUNICATIONS

IF24.9

2022-02-2230

OAAI

Exploring the oncostatin M (OSM) feed-forward signaling of glioblastoma via STAT3 in pan-cancer analysis

CANCER CELL INTERNATIONAL

IF6

2021-10-2625

OAAI

Th17 Cells in Periodontitis and Its Regulation by A20

牙周炎中的Th17细胞及其A20的调控

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-09-0741

OAAI

CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome

JOURNAL OF DENTAL RESEARCH

IF5.9

2021-07-1645

PREAI

Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-1812

OAAI

Bin Shao

个人简介

教育背景

工作经历

荣誉奖项

研究方向